Ataluren is a small-molecule therapeutic belonging to the read-through inhibitor class, primarily used to treat Duchenne muscular dystrophy resulting from nonsense mutations. By promoting the ribosomal… Read more












Ataluren is a small-molecule therapeutic belonging to the read-through inhibitor class, primarily used to treat Duchenne muscular dystrophy resulting from nonsense mutations. By promoting the ribosomal read-through of premature stop codons, this medication facilitates the production of functional proteins. To maintain rigorous quality control, analytical laboratories rely on a comprehensive range of reference standards, including the active pharmaceutical ingredient, identified impurities, and metabolites. Comprehensive impurity profiling is critical for ensuring product safety and regulatory compliance; therefore, this category provides structurally characterized synthetic intermediates, process-related impurities, and degradation products such as acyl glucuronides. Additionally, stable isotope labelled versions are available for use in bioanalytical testing and metabolic studies. These high-quality reference materials support precise method validation, stability testing, and structural characterization, enabling scientists to accurately monitor drug quality and identify related substances throughout the pharmaceutical lifecycle.